Validation Study of the Parkinson’s Disease Stigma Questionnaire (PDStigmaQuest)

The patient-reported 18-item PDStigmaQuest showed strong psychometric properties of validity and reliability. Our results suggest that the PDStigmaQuest can be used to assess and evaluate stigma comprehensively in PD, which will improve our understanding of the construct of PD stigma.

Authors

Institutions

Publication Details

Journal
Journal of Parkinson s Disease
Published
2024-09-26
DOI
https://doi.org/10.3233/jpd-240224
Citations
1
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.37

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Validation Study of the Parkinson’s Disease Stigma Questionnaire (PDStigmaQuest)

Stefanie T. Jost, Gereon R. Fink, Josef Kessler, Haidar S. Dafsari et al.
1 citations
Journal of Parkinson s Disease
Parkinson's Disease Mechanisms and Treatments
0.37
article

Validation Study of the Parkinson’s Disease Stigma Questionnaire (PDStigmaQuest)

Stefanie T. Jost, Gereon R. Fink, Josef Kessler, Haidar S. Dafsari, Anna Sauerbier, Georg Ebersbach, Alexandra Rizos, К. Ray Chaudhuri, Christina van der Linden, Jan Niklas Petry‐Schmelzer, Till A. Dembek, Lucia Batzu, Michael T. Barbe, Doreen Gruber, Vasilija Stopic, Julius Haupt, Gregor A. Brandt
article en
1 citations

Abstract

The patient-reported 18-item PDStigmaQuest showed strong psychometric properties of validity and reliability. Our results suggest that the PDStigmaQuest can be used to assess and evaluate stigma comprehensively in PD, which will improve our understanding of the construct of PD stigma.

Journal of Parkinson s DiseaseVol. 14(7)
University of Cologne (DE), King's College London (GB), South London and Maudsley NHS Foundation Trust (GB), Neurologisches Fachkrankenhaus für Bewegungsstörungen/Parkinson (DE), King's College Hospital (GB), University Hospital Cologne (DE), Otto-von-Guericke-Universität Magdeburg (DE)
International Parkinson and Movement Disorder Society, Boston Scientific Corporation, Wellcome Trust, EU Joint Programme – Neurodegenerative Disease Research, Parkinson's Foundation, National Institute for Health and Care Research, Parkinson's UK, Deutsche Forschungsgemeinschaft, Else Kröner-Fresenius-Stiftung, Deutsche Gesellschaft für Neurologie, Universität zu Köln, EVER Neuro Pharma, Thiemann Stiftung, Desitin Arzneimittel, Britannia Pharmaceuticals, Medical Research Council, UCB Pharma
Openalex Percentile: Top 35%
Parkinson's Disease Mechanisms and Treatments
0.37
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.